Logo image of CHSCP

CHS INC - CHSINC 8 PERP (CHSCP) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:CHSCP - US12542R2094

27.75 USD
-0.07 (-0.25%)
Last: 11/28/2025, 8:18:59 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CHSCP. CHSCP was compared to 87 industry peers in the Food Products industry. While CHSCP is still in line with the averages on profitability rating, there are concerns on its financial health. CHSCP has a expensive valuation and it also scores bad on growth. Finally CHSCP also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

CHSCP had a positive operating cash flow in the past year.
Each year in the past 5 years CHSCP has been profitable.
CHSCP had a positive operating cash flow in each of the past 5 years.
CHSCP Yearly Net Income VS EBIT VS OCF VS FCFCHSCP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

1.2 Ratios

CHSCP has a Return On Assets (2.61%) which is in line with its industry peers.
The Return On Equity of CHSCP (4.76%) is comparable to the rest of the industry.
Looking at the Return On Invested Capital, with a value of 0.05%, CHSCP is doing worse than 63.22% of the companies in the same industry.
CHSCP had an Average Return On Invested Capital over the past 3 years of 6.11%. This is significantly below the industry average of 28.38%.
The last Return On Invested Capital (0.05%) for CHSCP is well below the 3 year average (6.11%), which needs to be investigated, but indicates that CHSCP had better years and this may not be a problem.
Industry RankSector Rank
ROA 2.61%
ROE 4.76%
ROIC 0.05%
ROA(3y)8.28%
ROA(5y)6.12%
ROE(3y)15.4%
ROE(5y)11.43%
ROIC(3y)6.11%
ROIC(5y)4.27%
CHSCP Yearly ROA, ROE, ROICCHSCP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

Looking at the Profit Margin, with a value of 1.42%, CHSCP is in line with its industry, outperforming 45.98% of the companies in the same industry.
CHSCP's Profit Margin has improved in the last couple of years.
The Operating Margin of CHSCP (0.02%) is worse than 63.22% of its industry peers.
In the last couple of years the Operating Margin of CHSCP has declined.
With a Gross Margin value of 2.99%, CHSCP is not doing good in the industry: 90.80% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of CHSCP has remained more or less at the same level.
Industry RankSector Rank
OM 0.02%
PM (TTM) 1.42%
GM 2.99%
OM growth 3Y40.55%
OM growth 5Y-6.01%
PM growth 3Y24.89%
PM growth 5Y1.53%
GM growth 3Y21.71%
GM growth 5Y0.55%
CHSCP Yearly Profit, Operating, Gross MarginsCHSCP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1 2 3 4 5

3

2. Health

2.1 Basic Checks

CHSCP has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, CHSCP has a worse debt to assets ratio.
CHSCP Yearly Shares OutstandingCHSCP Yearly Shares OutstandingYearly Shares Outstanding 2018 2M 4M 6M 8M 10M
CHSCP Yearly Total Debt VS Total AssetsCHSCP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

CHSCP has an Altman-Z score of 2.23. This is not the best score and indicates that CHSCP is in the grey zone with still only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.23, CHSCP perfoms like the industry average, outperforming 54.02% of the companies in the same industry.
A Debt/Equity ratio of 0.34 indicates that CHSCP is not too dependend on debt financing.
CHSCP's Debt to Equity ratio of 0.34 is in line compared to the rest of the industry. CHSCP outperforms 57.47% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF N/A
Altman-Z 2.23
ROIC/WACC0.01
WACC4.81%
CHSCP Yearly LT Debt VS Equity VS FCFCHSCP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

2.3 Liquidity

A Current Ratio of 1.40 indicates that CHSCP should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.40, CHSCP is in line with its industry, outperforming 41.38% of the companies in the same industry.
CHSCP has a Quick Ratio of 1.40. This is a bad value and indicates that CHSCP is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.86, CHSCP perfoms like the industry average, outperforming 45.98% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.4
Quick Ratio 0.86
CHSCP Yearly Current Assets VS Current LiabilitesCHSCP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

1

3. Growth

3.1 Past

CHSCP shows a decrease in Revenue. In the last year, the revenue decreased by -8.96%.
The Revenue has been growing slightly by 4.24% on average over the past years.
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-8.96%
Revenue growth 3Y0.7%
Revenue growth 5Y4.24%
Sales Q2Q%1.63%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CHSCP Yearly Revenue VS EstimatesCHSCP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

1

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
CHSCP Price Earnings VS Forward Price EarningsCHSCP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CHSCP indicates a rather cheap valuation: CHSCP is cheaper than 91.95% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 3.81
CHSCP Per share dataCHSCP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 500 1K 1.5K 2K 2.5K

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

8

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 6.76%, CHSCP is a good candidate for dividend investing.
CHSCP's Dividend Yield is rather good when compared to the industry average which is at 5.06. CHSCP pays more dividend than 94.25% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.32, CHSCP pays a better dividend.
Industry RankSector Rank
Dividend Yield 6.76%

5.2 History

CHSCP has been paying a dividend for at least 10 years, so it has a reliable track record.
CHSCP has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years21
CHSCP Yearly Dividends per shareCHSCP Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

CHSCP pays out 32.94% of its income as dividend. This is a sustainable payout ratio.
DP32.94%
EPS Next 2YN/A
EPS Next 3YN/A
CHSCP Yearly Income VS Free CF VS DividendCHSCP Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B
CHSCP Dividend Payout.CHSCP Dividend Payout, showing the Payout Ratio.CHSCP Dividend Payout.PayoutRetained Earnings

CHS INC - CHSINC 8 PERP

NASDAQ:CHSCP (11/28/2025, 8:18:59 PM)

27.75

-0.07 (-0.25%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)11-04 2025-11-04
Earnings (Next)01-06 2026-01-06
Inst Owners11.67%
Inst Owner Change0.8%
Ins Owners0.03%
Ins Owner Change0%
Market Cap340.49M
Revenue(TTM)36.03B
Net Income(TTM)513.00M
Analysts0
Price TargetN/A
Short Float %0.09%
Short Ratio1.19
Dividend
Industry RankSector Rank
Dividend Yield 6.76%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP32.94%
Div Incr Years0
Div Non Decr Years21
Ex-Date12-16 2025-12-16 (0.5)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF N/A
P/OCF 0.71
P/B 0.03
P/tB 0.03
EV/EBITDA 3.81
EPS(TTM)N/A
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-26.32
FCFYN/A
OCF(TTM)38.96
OCFY140.38%
SpS2936.43
BVpS878.97
TBVpS878.97
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 2.61%
ROE 4.76%
ROCE 0.07%
ROIC 0.05%
ROICexc 0.05%
ROICexgc 0.05%
OM 0.02%
PM (TTM) 1.42%
GM 2.99%
FCFM N/A
ROA(3y)8.28%
ROA(5y)6.12%
ROE(3y)15.4%
ROE(5y)11.43%
ROIC(3y)6.11%
ROIC(5y)4.27%
ROICexc(3y)6.66%
ROICexc(5y)4.61%
ROICexgc(3y)6.79%
ROICexgc(5y)4.69%
ROCE(3y)8.06%
ROCE(5y)5.71%
ROICexgc growth 3Y38.36%
ROICexgc growth 5Y-3.28%
ROICexc growth 3Y37.82%
ROICexc growth 5Y-3.23%
OM growth 3Y40.55%
OM growth 5Y-6.01%
PM growth 3Y24.89%
PM growth 5Y1.53%
GM growth 3Y21.71%
GM growth 5Y0.55%
F-Score3
Asset Turnover1.83
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF N/A
Debt/EBITDA 5.94
Cap/Depr 131.31%
Cap/Sales 2.22%
Interest Coverage 250
Cash Conversion 77.22%
Profit Quality N/A
Current Ratio 1.4
Quick Ratio 0.86
Altman-Z 2.23
F-Score3
WACC4.81%
ROIC/WACC0.01
Cap/Depr(3y)104.21%
Cap/Depr(5y)89.6%
Cap/Sales(3y)1.35%
Cap/Sales(5y)1.27%
Profit Quality(3y)93.36%
Profit Quality(5y)103.6%
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-8.96%
Revenue growth 3Y0.7%
Revenue growth 5Y4.24%
Sales Q2Q%1.63%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-98.83%
EBIT growth 3Y41.53%
EBIT growth 5Y-2.03%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-109.49%
FCF growth 3Y1.79%
FCF growth 5Y-7.81%
OCF growth 1Y-87.82%
OCF growth 3Y18.88%
OCF growth 5Y2.23%

CHS INC - CHSINC 8 PERP / CHSCP FAQ

What is the fundamental rating for CHSCP stock?

ChartMill assigns a fundamental rating of 3 / 10 to CHSCP.


What is the valuation status for CHSCP stock?

ChartMill assigns a valuation rating of 1 / 10 to CHS INC - CHSINC 8 PERP (CHSCP). This can be considered as Overvalued.


Can you provide the profitability details for CHS INC - CHSINC 8 PERP?

CHS INC - CHSINC 8 PERP (CHSCP) has a profitability rating of 4 / 10.


How financially healthy is CHS INC - CHSINC 8 PERP?

The financial health rating of CHS INC - CHSINC 8 PERP (CHSCP) is 3 / 10.